Hulls Chris 4

What Happened

• Chris Hulls, a director of Life360 (LIF), exercised 27,000 derivative awards and sold 16,379 shares in an open-market transaction on May 28, 2026. The option exercise reported a purchase price of $8.19 per share (27,000 shares; $221,130 cash paid). The open-market sale was for a weighted average price of $40.34 per share (16,379 shares; proceeds ~$660,729). The filing also reports a 27,000-share derivative conversion recorded at $0.00 (reported as disposed).

Key Details

• Transaction date: 2026-05-28; Form 4 filed: 2026-06-01 (timely filing).
• Sale details: 16,379 shares sold, weighted average price $40.34; sale prices ranged $40.17–$40.87 per share (per footnote).
• Exercise details: 27,000 shares exercised at $8.19 each (total $221,130). The stock option is fully vested and exercisable (footnote).
• Reported plan: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted Dec 16, 2025 (pre-established plan; footnote).
• Holdings noted in filing: includes restricted stock units (149,318 RSUs) and shares underlying CDIs (585,938 CDIs) per footnotes; the filing does not state a single consolidated "shares owned after" total.
• Transaction codes: M = exercise/conversion of derivative; S = open-market sale.

Context

• This was an exercise of vested options followed by an open-market sale of a subset of the acquired/held shares. Such same-day exercises and sales are commonly used to cover exercise costs or diversify holdings; here the sale was made under a pre-set 10b5-1 plan, which is intended to limit claims of opportunistic timing. The filing is factual and timely — it does not indicate the insider’s motivations.